University of Missouri Archives - Medical Design Sourcing

Researchers develop wearable monitor that measures ECG and SCG signals simultaneously

A researcher examines the health monitor part of the wearable device under a microscope in Yan’s lab. [Image courtesy of Pate McCuien/University of Missouri]

Researchers at the University of Missouri received a $2.6 million grant from the NIH to develop a multifunctional, wearable heart monitor.

Funding helps the researchers create a breathable material with antibacterial and antiviral properties. This supports their ongoing development of the heart monitor.

According to a post on the university’s website, they designed the device to continuously track human heart health. It does so by monitoring dual signals simultaneously. Its electrocardiogram (ECG) function measures the heart’s electrical signal while a seismocardiogram (SCG) measures vibrations. After the recording on an electronic device, users can share their information with their healthcare provider to identify potential warnin…

Are Black patients not getting LVADs as quickly as white patients?

[Image from Wikimedia Commons]Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure.

According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest to help blood flow throughout the body — later in their disease progression when compared to white patients, ultimately resulting in worse health outcomes.

Get the full story at our sister site, Medical Design & Outsourcing.

Are Black patients not getting LVADs as quickly as white patients?

[Image from Wikimedia Commons]

Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure.

According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest to help blood flow throughout the body — later in their disease progression when compared to white patients, ultimately resulting in worse health outcomes.

MU School of Health Professions associate professor Adrianne Frech and fellow co-authors of the study analyzed data from the United Network for Organ Sharing (UNOS) that covered patients who received an LVAD as a temporary “bridge” solution to their heart failure while on a waiting list to receive a permanent heart transplant between 1999 and 2014.

Frech and the …